IRVINE, Calif.--(BUSINESS WIRE)--MiCardia® (MiCardia® Corporation, Irvine, California) today announced the completion of enrollment in its European “DYANA” (Dynamic Annuloplasty Activation) study, designed to support submission for CE mark of the firm’s Dynaplasty® technology in Europe.
